AAAAAA
Results:
1-7
|
Results: 7
Authors:
Quaschning, T
d'Uscio, LV
Shaw, S
Viswambharan, H
Ruschitzka, FT
Luscher, TF
Citation: T. Quaschning et al., Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension, NEPH DIAL T, 16(6), 2001, pp. 1176-1182
Authors:
Spieker, LE
Noll, G
Ruschitzka, FT
Luscher, TF
Citation: Le. Spieker et al., Endothelin receptor antagonists in congestive heart failure: A new therapeutic principle for the future?, J AM COL C, 37(6), 2001, pp. 1493-1505
Authors:
Quaschning, T
Corti, R
Ruschitzka, FT
Noll, C
Luscher, TF
Citation: T. Quaschning et al., Vasopeptidase inhibitors: clinical implications of a new class of drugs, DEUT MED WO, 125(16), 2000, pp. 499-503
Authors:
Spieker, LE
Noll, G
Ruschitzka, FT
Maier, W
Luscher, TF
Citation: Le. Spieker et al., Working under pressure: the vascular endothelium in arterial hypertension, J HUM HYPER, 14(10-11), 2000, pp. 617-630
Authors:
Ruschitzka, FT
Wenger, RH
Stallmach, T
Quaschning, T
de Wit, C
Wagner, K
Labugger, R
Kelm, M
Noll, G
Rulicke, T
Shaw, S
Lindberg, RLP
Rodenwaldt, B
Lutz, H
Bauer, C
Luscher, TF
Gassmann, M
Citation: Ft. Ruschitzka et al., Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin, P NAS US, 97(21), 2000, pp. 11609-11613
Authors:
Quaschning, T
Ruschitzka, FT
Maier, W
Luscher, TF
Citation: T. Quaschning et al., The role of the endothelium in the development and treatment of vascular disease, INTERNIST, 41(4), 2000, pp. 355-362
Authors:
Ruschitzka, FT
Noll, G
Luscher, TF
Citation: Ft. Ruschitzka et al., Calcium antagonists - Results of recent studies and their significance forpractice, INTERNIST, 40(2), 1999, pp. 225-234
Risultati:
1-7
|